1. Sorrell, T.C., Packham, D.R., Shanker, D.S., Foldes, M., Munro, R.: Vancomycin therapy for methicillin-resistantStaphylococcus aureus. Annals of Internal Medicine 1982, 97: 344–350.
2. Watanakunakorn, C.: Treatment of infections due to methicillin-resistantStaphylococcus aureus. Annals of Internal Medicine 1982, 97: 376–378.
3. Humphreys, H., Mulvihill, E.: Ciprofloxacin-resistantStaphylococcus aureus. Lancet 1985, ii: 383.
4. Søgaard, P., Hansen, B.G.: Population analysis of susceptibility to ciprofloxacin and nalidixic acid inStaphylococcus, Pseudomonas aeruginosa, andEnterobacteriaceae. Acta Pathologica Microbiologica et Immunologica Scandinavica (B) 1986, 94: 351–356.
5. Arpi, M., Gahrn-Hansen, B., Søgaard, P.: Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates. Acta Pathologica Microbiologica et Immunologica Scandinavica (B) 1987, 95: 141–146.